Deborah F Kelly

Deborah F Kelly i

Pennsylvania State University - University Park / United States
Engineering & Technology / Nanoscience and Nanotechnology
AD Scientific Index ID: 898493
person_outline Deborah F Kelly's MOST POPULAR ARTICLES
1-) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKM Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...The Lancet 397 (10269), 99-111, 202140752021
2-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative GroupLancet (London, England) 397 (10285), 1637, 20211800*2021
3-) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialMN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...The Lancet 396 (10267), 1979-1993, 202016342020
4-) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...The Lancet 397 (10277), 881-891, 202113942021
5-) Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trialCS Calfee, KL Delucchi, P Sinha, MA Matthay, J Hackett, M Shankar-Hari, ...The Lancet Respiratory Medicine 6 (9), 691-698, 20185872018